One of the most highly anticipated FDA decisions this month is for Alnylam Pharmaceuticals, which is seeking to expand the ...

Linezolid Nosocomial pneumonia, cSSSI Oral and intravenous form available, bacteriostatic, not approved for catheter-related bloodstream infections, side effects include myelosuppression ...

Ondine’s innovative light-activated antimicrobial treatment has the potential to become the first FDA-approved nasal decolonization treatment ... aureus in the nose is off-label use of the topical ...

Figure 2 shows the chemical structure of antibiotics that have been approved or are currently under development for the treatment of serious MRSA infections.